Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Joseph Newman

Undersea and Hyperbaric Medicine Joplin, MO Medical Doctor

NPI 1649213190 CMS profile 346979

1102 W 32Nd St, Joplin, MO 64804

Open in the dashboard

General payments

$246

8 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Joseph Newman of Joplin, MO is reported in the CMS Open Payments database as having received $246 across 8 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 34th percentile of Undersea and Hyperbaric Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $156 6
2021 General $88 1
2019 General $3 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Joseph Newman
  • Undersea and Hyperbaric Medicine median
  • Middle half of Undersea and Hyperbaric Medicine
  • National median

In program year 2025, general payments to Joseph Newman were reported at $156. Among 121 Undersea and Hyperbaric Medicine profiles paid that year, the median was $208 and the middle half received between $52 and $518.

Show as a table
Year Joseph Newman Undersea and Hyperbaric Medicine median Middle half National median
2019 $3 $201 $85–$538 $163
2020 $0 $84 $31–$222 $114
2021 $88 $138 $52–$383 $132
2022 $0 $135 $51–$385 $149
2023 $0 $143 $75–$442 $160
2024 $0 $178 $80–$442 $164
2025 $156 $208 $52–$518 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $88 1 payment
  2. Organogenesis Inc. $66 3 payments
  3. Janssen Biotech, Inc. $48 2 payments
  4. Solventum Corporation $42 1 payment
  5. Aroa Biosurgery Incorporated $3 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $246 8 payments
Products named General payments · program years 2019–2025
  1. Ellipsys $88 1 payment
  2. TREMFYA $48 2 payments
  3. ACTIV.A.C. $42 1 payment
  4. APLIGRAF $30 1 payment
  5. PURAPLY WOUND MATRIX $20 1 payment
  6. Affinity $16 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 12 drugs

Part D claims

523

Prescriptions dispensed, refills included

Drug cost

$6,120

Paid at the pharmacy, in all

Branded share of claims

45.7%

Brand-name drugs, not generics

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ssd Silver Sulfadiazine Brand 72 $2,278
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 122 $1,236
Silver Sulfadiazine Generic 19 $803
Ciprofloxacin Hcl Generic 66 $397
Cephalexin Generic 85 $355
Triamcinolone Acetonide Generic 17 $271
Doxycycline Hyclate Generic 44 $250
Lidocaine-Prilocaine Lidocaine/Prilocaine Brand 14 $241
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 12 $152
Levofloxacin Generic 26 $84

The 10 drugs with the highest cost, of 12 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero.

Billing to Medicare

Part B · data year 2024 · 26 billing codes

Paid by Medicare

$103,479

Medicare's payments for the services billed

Medicare patients

227

Average age 73

Services billed

1,910

110 women, 117 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 55%
Diabetes 52%
Ischemic heart disease 47%
Chronic kidney disease 38%
Heart failure 36%
Atrial fibrillation 34%
COPD 32%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

8 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Undersea and Hyperbaric Medicine in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record